Latin American Cooperative Oncology Group

This study tests a combination of three drugs (amivantamab, lazertinib, and pemetrexed) as a first treatment for people with advanced non-small cell lung cancer that has a specific genetic change called an EGFR mutation. The goal is to see if this combo can keep the cancer from g…

This study aimed to see if a person's race changes how well a combination of two drugs (niraparib and abiraterone acetate plus prednisone) works for a certain type of advanced prostate cancer. It planned to enroll Black, Hispanic, White, and Native American men whose cancer had s…

This study looks at whether some women with HER2-positive early breast cancer can be treated with just the targeted drugs pertuzumab and trastuzumab (PHESGO™) without chemotherapy. Researchers use specific markers to pick patients whose tumors depend heavily on HER2. The goal is …

This study tests a new approach called extreme bipolar androgen therapy (ExBAT) for men with a hard-to-treat type of advanced prostate cancer. It combines a standard drug (darolutamide) with high doses of testosterone to try to control the cancer. The study includes 51 men and ai…